Sphere Medical Holding PLC (LON:SPHR)‘s stock had its “buy” rating reissued by analysts at Panmure Gordon in a research note issued on Friday. They presently have a GBX 17 ($0.22) target price on the stock. Panmure Gordon’s target price indicates a potential upside of 44.68% from the stock’s previous close.
Shares of Sphere Medical Holding PLC (LON:SPHR) opened at 11.9222 on Friday. The firm’s 50-day moving average is GBX 11.74 and its 200-day moving average is GBX 11.05. Sphere Medical Holding PLC has a 1-year low of GBX 6.00 and a 1-year high of GBX 15.00. The company’s market capitalization is GBX 16.90 million.
About Sphere Medical Holding PLC
Sphere Medical Holding PLC is a United Kingdom-based Company specializing in the development of medical monitoring and diagnostic equipment. The Company’s products include Proxima and Pelorus. Proxima is an arterial blood gas analyser which supports rapid and frequent measurement. It is operated using the dedicated bedside monitor with touch screen interface.
Receive News & Ratings for Sphere Medical Holding PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sphere Medical Holding PLC and related companies with MarketBeat.com's FREE daily email newsletter.